Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Medicus Pharma has received FDA clearance to begin a Phase [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Telix has dosed the first patient in a Phase 3 [...]

Deep Origin’s computational platform helped identify a molecular glue compound [...]

Kairos Pharma has reported positive interim safety results from an [...]

The European Commission has approved Erbitux (cetuximab) in combination with [...]

The US FDA has granted Fast Track Designation to SOTIO [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]